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SEBACEOIJS GLANDS OF MICEt
F. NEUMANN, D.V.M. AND W. ELGER
Endocrine disturbances very often involve
structural and functional changes of the skin
(1, 2 and others). The sebaceous glands par-
ticularly are affected hormonally as regards
their development and activity.
It has been demonstrated in man (1, 3, 4, 5)
as well as in various animal species such as the
rat (6,7, 8,9), mouse (10), golden hamster (11)
and rabbit (12) that androgens induce the
growth and activity of sebaceous glands. Estro-
gens, on the other hand, have the opposite
effect (1, 6, 13, 14, 15, 16). Following castration,
the sebaceous glands show a reduction in num-
ber and size (1, 6). In man, they are barely
developed and almost completely undifferenti-
ated before puberty (1). During puberty, they
are frequently and significantly enlarged. The
development of acne has been attributed to the
marked growth of the sebaceous glands, which
is induced by increased production of testoster-
one in this phase of development (1). There
is no evidence that production of testosterone
is excessive during this period. Castration leads
to a decrease of sebaceous secretion (1). In fe-
males with adrenal cortical tumors, acne is of-
ten observed (17). Furthermore, testosterone
administration in females contributes to the de-
velopment of acne (18, 19).
It is, therefore, without question that testos-
terone (androgens) have a stimulant effect on
sebaceous glands. The effect of testosterone is
explained by increased cell proliferation and
moderate enlargement of the glandular cells
(6,9).
In this paper, the effect of an antiandrogenic
steroid, cyproterone acetate, on the develop-
ment and size of sebaceous glands in mice is
investigated quantitatively and qualitatively.
As we were able to show in earlier studies with
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cyproterone acetate, the compound counteracts
testosterone in various functional or morpho-
logically testosterone-dependent organ systems,
which led us to suspect the same mechanism of
action as regards the development of sebaceous
glands (20, 21, 22, 23). Moreover, the testoster-
one propionate-stimulated growth of the pre-
putial glands, which are histologically similar
to the sebaceous glands, could be inhibited with
cyproterone acetate. There is also a report by
Lerner (24), who mentioned the possibility of
an influence on sebaceous glands by antiandro-
gens; he noted a decrease of sebaceous gland
cells in the alveoli of the glands after administra-
tion of A-norprogesterone to juvenile castrated
rats. Moreover, the effect of antiandrogens on
the response of rat preputial glands to testoster-
one has also been reported by Jones and Wood-
bury (28).
MATERIAL AND METHODS
We used as experimental male NMRI mice as ex-
perimental animals with a starting weight of about
20gm. The animals were grouped as follows: Group
1—intact male mice; Group 2—intact male mice
treated with intramuscular doses of 1 mg cyproter-
one acetate/animal every other day for 4 weeks;
Group 3—castrated male mice treated with intra-
muscular doses of 0.5 mg testosterone propionate/
animal every other day for 4 weeks; Group 4—
castrated male mice treated with intramuscular
doses of 0.5 mg testosterone propionate and 1 mg
cyproterone acetate/animal every other day for 4
weeks.
Six to eight animals were tested in each group.
The duration of the test period was four weeks.
After a test period of fourteen days, a skin area of
about 1 cm2 on the lower back was plucked in or-
der to study the effect of the antiandrogen on hair
regeneration. After a test period of four weeks, the
animals were sacrificed and the body weight as
well as the weight of the seminal and preputial
glands was determined.
For the histological study, an area of 1.5 to 2 cm
by 0.5 cm of skin from the back was excised and
fixed in 10% formajin. After these pieces were im-
bedded in paraffin, sections of 5 thickness were
prepared and stained with hematoxylin-eosin.
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TABLE I
Seminal vesicle and preputial gland weights of mice
1. Intact male animals—Controls
(Solvent only)
2. Intact male animals, after 4 weeks;
animals received 1 mg A.A.+ I.M. q.
2nd day
3. Castrated male animals, after 4
weeks; animals received 0.5 mg.
T.P.++ I.M. q. 2nd day
4. Castrated male animals, after 4
weeks; animals received 0.5 mg.
T.P.++ and 1 mg A.A.+ I.M. q. 2nd
day
A.A.+ = 6-chloro-17-hydroxy-la,2a-methylenepregna4, 6-diene-3, 20-dione acetate (cyproterone
acetate)
T.P.++ = Testosterone propionate
Mean deviation
Quantitative Evaluation of the Sebaceous
Glands
In each animal a skin section of 1 cm in length
and with a thickness of 5 JL was evaluated quanti-
tatively. The number of alveoli in the sebaceous
glands and the number of the glandular cells per
alveolus were determined (the cells in a total of 20
alveoli were counted); the cell diameter of 40
glandular cells in various alveoli was determined
for each section. By means of the cell diameter the
relative cell volume was calculated according to
the formula 4/3r3 X w, since we assumed the cells
of the sebaceous glands to be almost spherical. The
total volume of sebaceous tissue was calculated as
follows: average relative cell volume X average
number of counted glandular cells per alveolus X
the number of alveoli in the skin areas of the eval-
uated length of skin.
RESULTS
The organ weights of the sacrificed animals
are ifiustrated in Table I.
The table depicts that the treatment with
cyproterone acetate also affects body weight.
The body weight of Groups 2 and 4 is lower
than that of Groups 1 and 3. The weight of the
seminal glands of intact animals treated with
cyproterone acetate was reduced to /s of that
of animals receiving only the solvent. In addi-
tion, the growth of the seminal glands in cas-
trated male mice (Group 3) induced by testos-
terone propionate is reduced with concurrent
administration of antiandrogens (Group 4).
The weight of the preputial glands shows
the same relationship. The testosterone propio-
nate-treated castrated animals of Group 3
showed higher preputial gland weights than the
intact control animals of Group 1. With the ad-
ministration of cyproterone acetate, the weights
of the preputial glands are significantly reduced
in intact as well as in castrated animals treated
with testosterone propionate.
The results of the quantitative evaluation of
the sebaceous glands are shown in Table II.
The number of alveoli in the sebaceous glands
in castrated animals treated with testosterone
propionate was 3 times as high as in intact
control animals. (See Groups 1 and 2). The
simultaneous administration of cyproterone ace-
tate almost completely inhibits the effect of
testosterone propionate on the number of se-
baceous gland alveoli. (See Groups 3 and 4).
The antiandrogen treatment of intact animals
led to a 50% decrease in the number of glandu-
lar alveoli. (See Groups 1 and 2).
The number of glandular cells in the alveolus
showed a similar relationship. The differences
are not quite as distinct, however; but are stifi
considered highly significant. Concurrent treat-
ment with testosterone propionate and cypro-
Group Number ofanbnals
Body weight
Beginning
weight
Organ weight in mg
End
weight
Seminal
vesicle
21 0.4 26
Preputial
glands
22±0.4 18± 1.3
162±18 61±6.28
7
8
6
45 8.6 44 7.6
23±0.4 26±1.0 361±27 82 14
21±0.5 22±1.0 290±32 54±7.4
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Fic. 1. 0—0, group 1 (intact male mice).
•- - -•, group 2 (intact male mice treated with
i.m. doses of 1 mg cyproterone acetate/animal every
other day for 4 weeks). R group 3 (castrated
male mice treated with i.m. doses of 0.5 mg testos-
terone propionate/animal every other day for 4
weeks). •—•, group 4 (castrated male mice
treated with i.m. doses of 0.5 mg testosterone pro-
pionate + 1 mg cyproterone acetate/animal every
other day for 4 weeks).
terone acetate results in a reduction of the
number of glandular cells in the alveoli as com-
pared with intact control animals. The differ-
ences between the individual test groups as re-
gards cell diameter is relatively small as may
be seen in Table II when only numbers are con-
sidered. To give a more detailed picture of the
differences, a distribution curve for the cell
diameter is shown in Fig. 1. The number of
smaller cells (about 8 to 13 ) is significantly
elevated in those animals receiving antiandro-
gen. Maximum values of the distribution curve
of these groups of animals are, therefore, other
than those of intact and untreated animals or
castrated animals treated with testosterone
propionate at smaller cell diameters. On calcu-
lation of the average cell volume the differences
between the individual groups becomes greater
again, since a decrease in diameter of the spheri-
cal cell represents a decrease of its cell volume
to the third power. The cell volume is highest
in the castrated animals treated with testoster-
one (Group 3) and decreased with concurrent
administration of cyproterone acetate far below
the normal limit (See Groups 3 and 4 and
Groups 3 and 1). The smallest cell volumes of
the sebaceous glands were found in intact ani-
mals treated with cyproterone acetate. They
were more than half the size of those in intact
animals. (See Groups 1 and 2).
In all of the above-mentioned criteria (num-
ber of sebaceous gland alveoli, number of cells
per alveolus as well as cell diameter and cell
volume), the inhibitory effect of the antiandro-
gen on the sebaceous glands becomes obvious.
With the calculation of the relative volume of
sebaceous gland tissue in a skin area of 50,000
2 (1 cm long and 5 jz in width), all the above-
mentioned criteria are included in the calcula-
tions as may be seen in the two last columns
of Table II. The treatment of intact male mice
with cyproterone acetate leads to a reduction
of the relative sebaceous gland volume of more
than 80% (see Groups 1 and 2). With testoster-
one propionate treatment of castrated animals,
the relative volume increases 4 times in com-
parison with intact, untreated animals (see
Groups 1 and 3). With concurrent administra-
tion of cyproterone acetate and testosterone
propionate the normal limit is again reached or
even slightly decreased (see Groups 1 and 3).
As regards the degree of activity, it may be of
considerable interest to know that 1 mg of
antiandrogen is sufficient to counteract the
effect of 0.5 mg testosterone propionate.
The qualitative findings are depicted in some
histological pictures.
Figure 2 shows (a) the skin section of an
intact animal treated with the diluent only;
(b) an animal treated with cyproterone acetate.
In Figure 2a, well-developed sebaceous glands
may be seen alongside the hair follicle, while
these are completely atrophic and very faint
in appearance in Figure 2b.
With greater magnification (Figures 3a and
3b) these findings are more distinct. In those
with cyproterone acetate treated animals, the
sebaceous glands are markedly atrophic (Fig-
ure 3b, on the right side of the picture) or the
number of cells per alveolus is decreased (Fig-
ure 3b, left side of the picture).
In Figure 4a, b and c, the skin sections of
castrated animals treated with testosterone pro-
pionate are shown. The animals whose skin
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sections are depicted in Figure 4d, e and 1,
also received cyproterone acetate.
Treatment with testosterone propionate mark-
edly stimulates the growth of sebaceous glands.
The number of the glandular alveoli per glandu-
lar unit (always surrounding one hair follicle)
is very high as is the number of glandular cells
per alveolus (Figure 4a, b and c). In animals
also treated with cyproterone acetate, the smaller
number of glandular alveoli and number of cells
per alveolus are clearly shown (Figure 4d,
e and f). With greater magnification (5a, b, c,
and d) the atrophy of the sebaceous glands
occurring after concurrent administration of
cyproterone acetate and testosterone propionate,
is well illustrated as compared with the animals
only receiving testosterone propionate. Thus the
sebaccous glands are occasionally not very dis-
tinctly depicted.
On examination of Figure 5, it appears that
the epidermis in the castrated animals receiving
testosterone propionatc and cyproteronc acetate
is not as thick as that in animals receiving only
testosterone propionatc. The same observation
appears to be true for the keratinous skin layer.
As shown in Figure 6, hair regeneration is
inhibited by cyproteronc acetate.
Figure Ga shows castrated male animals re-
ceiving testosterone propionate. Figure Gb de-
picts animals also given cyprotcrone acetate in
addition to testosterone propionate. In both
groups, the hair was plucked in an area of 1
cm2 13 days before the pictures were taken. In
the animals only treated with testosterone pro-
pionate, the hairless areas are almost covered
while those also receiving cyproterone acetate
hardly show any tendency for hair regeneration.
Similar findings were observed in Groups 1 and
2 (intact and animals treated only with diluent
and intact and with cyprotcrone acetate treated
animals). The differences in regard to hair re-
generation were not so pronounced as between
Groups 3 and 4.
DI5CTJS SIGN
As has been shown, an effect on the schaceous
glands with antiandrogcn is possible, without
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FIG. 2. (o) Skin section of an intact male mouse, treated with diluent only. (b) Skin
section of an intact male mouse receiving 1 mg cyproterone acetate intramuscularly every
2nd day over a period of 4 weeks. Magnification: about 120 X.
r. .s . -.
-.4- .4
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Fm. 3. (a and b) Same experimental setup, increased magnification (300 X)
regard to whether the animals were intact or
castrated and treated with testosteroae pro-
pionate. In each case, the number of the seba-
eeous glaad alveoli, as well as the number of cells
per alveolus and the cell size decreased. With
estrogen it is possible to inhibit the effect of
endogeaous testosterone, but not that of exog-
enous testesterone, as could be demonstrated
in man (1) and in animals (5, 13).
Estrogens have a marked central inhibitory
effect and bring about decreased production of
testosterone in interstitial cells of the testes via
a decrease in gonadotropin secretion and/or
production. This action is affirmed by the fact
that with local application of ethinyl estradiol
in man, the regression of sebaceous glands is as
great on the contralateral untreated side as it is
on the treated area. In addition, the timing of
the sebaceous gland regression shows no differ-
ence between the treated and untreated areas
(1).
Since cproterone acetate also inhibits exog-
enous testosterone, in contrast to estrogens,
we must here be dealing with a competitive
testosterone antagonism, which can also be
shown on other functional and morphologically
testosterone-dependent organs and organ sys-
tems (21, 22).
What influence the antiandrogen we used
has on the proliferation rate and turn-over rate
of the scbaccous cells is still not known.
From the figures, it appears that the thickness
of the epidermis is decreased following treat-
ment vith an antiandrogen. From other investi-
gations it is also known that testosterone
propionate elicits a broadening of the epidermis
(15, 25, 26). In addition, Lbuppi and Studcr
(26, 27) have shown that the proliferation of
rat epidermis induced by administration of
androgens, bilateral adrcnalcctomy or by hyper-
vitaminosis A can be inhibited by the applica-
I.—
-, 
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Fm. 4. (a, b and c) Skin sections of castrated male mice receiving 0.5 mg testosterone
propionate intramuscularly every 2nd day for 4 weeks. (d, e and f) Skin sections of cas-
trated male mice receiving 0.5 mg testosterone propionate and 1 mg cyproterone acetate
intramuscularly every 2nd day for 4 weeks. Magnification: 120 X.
tion of an antiandrogenic derivative of phenan-
threne.
The influence on hair regeneration described
above can not simply be explained on the basis
of a testosterone propionate antagonism, since
the possible stimulating effect of testosterone
propionate on hair growth is still debated.
5UMMARY
The effect of a new antiandrogenic steroid,
6-chloro-17—hydroxy-la , 2a-methylenepregna-4,
6-diene-3,20-dione acetate (cyproterone acetate)
on sebaceous glands of mature male mice as
well as mature castrated mice treated with
testosterone propionatc has been studied quali-
tatively and quantitatively. A dosage of 1 mg
cproterone acetate every second day for a
period of 4 weeks induces a reduction of the
relative total sebaceous gland volume of about
50% in intact mice. The stimulant effect of 0.5
mg testosterone propionate every second day
and over a period of 4 weeks on sebaceous glands
is inhibited by the simultaneous treatment with
1 mg cyproterone acetate every second day. The
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FIG. 4—continued.
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Fie. 5. (a, b and c) Skin sections of castrated male mice receiving 0.5 mg testosterone
propionate intramuscularly every 2nd day for 4 weeks. (c and d) Same experimental setup,
higher magnification (300 X).
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Fio. 5—continued.
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a
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FIG. 6. Hair growth 13 days after plucking of
hair in 1 skin area the size of 1 cm2 in castrated
male mice, receiving (a) 0.5 mg testosterone
propionate every 2nd day and (b) 0.5 mg testos-
terone propionate and 1 mg cyproterone acetate
intramuscularly every 2nd day.
effect of cyproterone acetate produces a de-
crease of the number of sebaceous gland alveoli,
elicits a reduction of the number of cells per
alveolus as well as a decline in cell size.
The thickness of the epidermis was decreased
in the animals treated with cyproterone acetate.
The mechanism of action of this antiandrogen
has been explained by a competitive testosterone
antagonism since, in contrast to estrogens, the
stimulant effect of exogenous testosterone on
sebaceous glands is also inhibited.
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